273 related articles for article (PubMed ID: 29564984)
1. Molecular Modeling Studies on Some Important Anticancer Heterocycles: An Overview.
Kale M; Sonwane G; Nawale R; Mourya V
Curr Comput Aided Drug Des; 2018; 14(3):178-190. PubMed ID: 29564984
[TBL] [Abstract][Full Text] [Related]
2. Role of sulphur-heterocycles in medicinal chemistry: An update.
Pathania S; Narang RK; Rawal RK
Eur J Med Chem; 2019 Oct; 180():486-508. PubMed ID: 31330449
[TBL] [Abstract][Full Text] [Related]
3. A Comprehensive Review of N-Heterocycles as Cytotoxic Agents.
Kumar D; Jain SK
Curr Med Chem; 2016; 23(38):4338-4394. PubMed ID: 27516198
[TBL] [Abstract][Full Text] [Related]
4. A Medicinal Chemist's Perspective Towards Structure Activity Relationship of Heterocycle Based Anticancer Agents.
Nehra B; Mathew B; Chawla PA
Curr Top Med Chem; 2022; 22(6):493-528. PubMed ID: 35021975
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in the chemistry and biology of pyridopyrimidines.
Buron F; Mérour JY; Akssira M; Guillaumet G; Routier S
Eur J Med Chem; 2015 May; 95():76-95. PubMed ID: 25794791
[TBL] [Abstract][Full Text] [Related]
6. Heterocyclic Anticancer Compounds: Recent Advances and the Paradigm Shift towards the Use of Nanomedicine's Tool Box.
Martins P; Jesus J; Santos S; Raposo LR; Roma-Rodrigues C; Baptista PV; Fernandes AR
Molecules; 2015 Sep; 20(9):16852-91. PubMed ID: 26389876
[TBL] [Abstract][Full Text] [Related]
7. Improving the odds of success in antitumoral drug development using scoring approaches towards heterocyclic scaffolds.
Ion GND; Olaru OT; Nitulescu G; Olaru II; Tsatsakis A; Burykina TI; Spandidos DA; Nitulescu GM
Oncol Rep; 2020 Aug; 44(2):589-598. PubMed ID: 32627025
[TBL] [Abstract][Full Text] [Related]
8. Oxygen- and Sulphur-Containing Heterocyclic Compounds as Potential Anticancer Agents.
Sachdeva H; Khaturia S; Saquib M; Khatik N; Khandelwal AR; Meena R; Sharma K
Appl Biochem Biotechnol; 2022 Dec; 194(12):6438-6467. PubMed ID: 35900713
[TBL] [Abstract][Full Text] [Related]
9. Cancer chemotherapy and heterocyclic compounds.
Kidwai M; Venkataramanan R; Mohan R; Sapra P
Curr Med Chem; 2002 Jun; 9(12):1209-28. PubMed ID: 12052173
[TBL] [Abstract][Full Text] [Related]
10. An insight into the biological activities of heterocyclic-fatty acid hybrid molecules.
Venepally V; Reddy Jala RC
Eur J Med Chem; 2017 Dec; 141():113-137. PubMed ID: 29031060
[TBL] [Abstract][Full Text] [Related]
11. Importance of molecular computer modeling in anticancer drug development.
Geromichalos GD
J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
[TBL] [Abstract][Full Text] [Related]
12. Nitrogen-containing heterocyclic quinones: a class of potential selective antitumor agents.
Garuti L; Roberti M; Pizzirani D
Mini Rev Med Chem; 2007 May; 7(5):481-9. PubMed ID: 17504183
[TBL] [Abstract][Full Text] [Related]
13. Updates on Receptors Targeted by Heterocyclic Scaffolds: New Horizon in Anticancer Drug Development.
Kharb R
Anticancer Agents Med Chem; 2021; 21(11):1338-1349. PubMed ID: 32560614
[TBL] [Abstract][Full Text] [Related]
14. Overview on the current status on virtual high-throughput screening and combinatorial chemistry approaches in multi-target anticancer drug discovery; Part II.
Geromichalos GD; Alifieris CE; Geromichalou EG; Trafalis DT
J BUON; 2016; 21(6):1337-1358. PubMed ID: 28039691
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationship (SAR) study and design strategies of nitrogen-containing heterocyclic moieties for their anticancer activities.
Akhtar J; Khan AA; Ali Z; Haider R; Shahar Yar M
Eur J Med Chem; 2017 Jan; 125():143-189. PubMed ID: 27662031
[TBL] [Abstract][Full Text] [Related]
16. Recent Advances and Developments of in vitro Evaluation of Heterocyclic Moieties on Cancer Cell Lines.
Tandon R; Singh I; Luxami V; Tandon N; Paul K
Chem Rec; 2019 Feb; 19(2-3):362-393. PubMed ID: 29943894
[TBL] [Abstract][Full Text] [Related]
17. The Current Status of O-Heterocycles: A Synthetic and Medicinal Overview.
Singh PK; Silakari O
ChemMedChem; 2018 Jun; 13(11):1071-1087. PubMed ID: 29603634
[TBL] [Abstract][Full Text] [Related]
18. 4-Thiazolidinone-Bearing Hybrid Molecules in Anticancer Drug Design.
Roszczenko P; Holota S; Szewczyk OK; Dudchak R; Bielawski K; Bielawska A; Lesyk R
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361924
[TBL] [Abstract][Full Text] [Related]
19. Recent Advances in the Synthesis and Anticancer Activity of Some Molecules Other Than Nitrogen Containing Heterocyclic Moeities.
Akhtar MJ; Yar MS; Khan AA; Ali Z; Haider MR
Mini Rev Med Chem; 2017; 17(17):1602-1632. PubMed ID: 27804888
[TBL] [Abstract][Full Text] [Related]
20. Naturally Occurring O-Heterocycles as Anticancer Agents.
Avula SK; Das B; Csuk R; Al-Harrasi A
Anticancer Agents Med Chem; 2022; 22(19):3208-3218. PubMed ID: 34749628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
